Skip to main content

Table 3 Detection of HCV RNA in infected then treated Huh 7.5 cells a

From: Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus

Protein Protein conc. (mg/ml) Calc. conc. (IU/ml) Relative activity (%)
Control Positive 53910 0.0 ± 0.01
Negative 0.0 100 ± 0.0
Lactoferrin (first dose) 0.25 26110 51.56 ± 0.038
0.5 12430 76.94 ± 0.02
0.75 2210 95.59 ± 0.045
1.0 0.0 100 ± 0.0
1.25 0.0 100 ± 0.0
N-lobe 0.25 520 99.03 ± 0.023
0.5 0.0 100 ± 0.0
0.75 0.0 100 ± 0.0
1.0 0.0 100 ± 0.0
1.25 0.0 100 ± 0.0
C-lobe (first dose) 0.25 40790 24.33 ± 0.032
0.5 24070 55.35 ± 0.046
0.75 13320 75.29 ± 0.033
1.0 1030 98.08 ± 0.041
1.25 0.0 100 ± 0.0
Lactoferrin (second dose) 0.25 6290 88.33 ± 0.012
0.5 580 98.92 ± 0.03
0.75 0.0 100 ± 0.0
C-lobe (second dose) 0.25 33950 37.02 ± 0.026
0.5 12370 77.05 ± 0.011
0.75 0.0 100 ± 0.0
  1.0 0.0 100 ± 0.0
  1. aReal time PCR data for in vitro cLF, C- and N-lobe activity-treatment against HCV-infected Huh 7.5 cells. Huh 7.5 cells served as negative control, and infected Huh 7.5 cells with HCV served as positive control.